A Novel I221 L Substitution in Neuraminidase Confers High Level Resistance to Oseltamivir in Influenza B Viruses.
Escuret, V., Collins, P.J., Casalegno, J., Vachieri, S.G., Cattle, N., Ferraris, O., Sabatier, M., Frobert, E., Caro, V., Skehel, J.J., Gamblin, S., Valla, F., Valette, M., Ottmann, M., Mccauley, J.W., Daniels, R.S., Lina, B.(2014) J Infect Dis 210: 1260
- PubMed: 24795482 
- DOI: https://doi.org/10.1093/infdis/jiu244
- Primary Citation of Related Structures:  
4CPL, 4CPM, 4CPN, 4CPO, 4CPY, 4CPZ - PubMed Abstract: 
Influenza B viruses with a novel I221L substitution in neuraminidase (NA) conferring high-level resistance to oseltamivir were isolated from an immunocompromised patient after prolonged oseltamivir treatment.
Organizational Affiliation: 
Laboratoire de Virologie et Centre National de Référence virus influenzae Laboratoire Virpath EA4610, Faculté de Médecine Lyon Est, Université Claude Bernard Lyon 1, Université de Lyon, and.